Fay Burrows
St. Vincent's Health System
18 Papers
28 Citations
Fay Burrows is an academic researcher from St. Vincent's Health System. The author has contributed to research in topics: Medicine & Dosing. The author has an hindex of 4, co-authored 9 publications.
Chat about Author
Papers
Donor heart and lung procurement: A consensus statement
Hannah Copeland,J.W. Awori Hayanga,Arne Neyrinck,Peter S. Macdonald,Göran Dellgren,Alejandro Bertolotti,Tam Khuu,Fay Burrows,Jack G. Copeland,Danyel Gooch,Amy Elizabeth Hackmann,David Hormuth,Christa Kirk,V. Linacre,H. Lyster,Silvana Marasco,David C. McGiffin,Priya Nair,Axel O. Rahmel,Michael Sasevich,Martin Schweiger,Aleem Siddique,Timothy J. Snyder,William E. Stansfield,Steven Tsui,Yishay Orr,Patricia Uber,Rajimyer Venkateswaran,Jasleen Kukreja,Michael S. Mulligan +29 more
TL;DR: An international consensus statement on donor heart and lung procurement is designed to serve as a guide for physicians, surgeons, and other providers who manage donors to best optimize the clinical status for the procurement of both heart and lungs for transplantation.
136
ASAP ECMO: Antibiotic, Sedative and Analgesic Pharmacokinetics during Extracorporeal Membrane Oxygenation: a multi-centre study to optimise drug therapy during ECMO
Kiran Shekar,Jason A. Roberts,Susan A Welch,Hergen Buscher,Sam Rudham,Fay Burrows,Sussan Ghassabian,Steven C. Wallis,Bianca J. Levkovich,Vin Pellegrino,Shay McGuinness,Rachael Parke,Eileen Gilder,Adrian G. Barnett,James Walsham,Daniel V. Mullany,Yoke Lin Fung,Maree T. Smith,John F. Fraser +18 more
TL;DR: This study was designed to describe the pharmacokinetics of the commonly used antibiotic, analgesic and sedative drugs in adult patients receiving ECMO to develop dosing guidelines for prescription during ECMO.
Oral ribavirin for respiratory syncytial virus infection after lung transplantation: Efficacy and cost-efficiency.
Fay Burrows,L. Carlos,M. Benzimra,Deborah Marriott,Adrian Havryk,Marshall Plit,Monique A. Malouf,Allan R. Glanville +7 more
TL;DR: Oral Ribavirin appears to be an effective, well-tolerated alternative to IV or inhaled ribavirin; provides considerable cost savings and reduces length of hospital stay; and potential long-term benefits in preventing development of chronic lung allograft dysfunction are yet to be determined.
59
Medication Error Minimization Scheme (MEMS) in an adult tertiary intensive care unit (ICU) 2009-2011.
Jeff Breeding,S. Welch,S. Welch,Susan Whittam,Hergen Buscher,Fay Burrows,Carmen Frost,Maryke Jonkman,N. Mathews,Khai Shin Wong,Alison Wong +10 more
TL;DR: This project demonstrated that measurable, "non-incident report" errors can be reduced by focusing upon and promoting medication safety in the ICU, and demonstrated a workplace that values medication safety, the discovery of shortfalls and the benefits of ongoing improvement.
25
Antimicrobial Exposures in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation.
Kiran Shekar,Mohd H. Abdul-Aziz,Vesa Cheng,Fay Burrows,Hergen Buscher,Young Jae Cho,Amanda Corley,Anke Diehl,Eileen Gilder,Stephan M. Jakob,Hyung-Sook Kim,Bianca J. Levkovich,Sung Yoon Lim,Shay McGuinness,Rachael Parke,Vincent Pellegrino,Yok-Ai Que,Claire Reynolds,Sam Rudham,Steven C. Wallis,Susan A Welch,David Zacharias,John F. Fraser,Jay Roberts +23 more
TL;DR: Antimicrobial pharmacokinetics were highly-variable in critically ill patients receiving ECMO leading to poor target attainment rates and large variations in antimicrobial concentrations seen leading to more than five-fold variations in all PK parameters across all study antimicrobials.
23